Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Crinetics Pharmaceuticals

    Client Virtual Booth

    CRINETICS PHARMACEUTICALS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Crinetics Pharmaceuticals
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    6197 Cornerstone Court, Suite 111 San Diego, CA 92121
    Telephone
    Telephone
    1-858-450-6464
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://crinetics.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/crinetics-pharmaceuticals
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Crinetics April 2024 Inducement Grants Under Nasdaq 5635(c)(4)
    Crinetics April 2024 Inducement Grants Under Nasdaq 5635(c)(4)

    https://www.globenewswire.com/news-release/2024/04/11/2861860/0/en/Crinetics-Pharmaceuticals-Announces-April-2024-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    11 Apr 2024
    Share Share
    Crinetics Bags Second Phase III Win for Acromegaly, Heads for NDA Submission
    Crinetics Bags Second Phase III Win for Acromegaly, Heads for NDA Submission

    https://www.biospace.com/article/crinetics-bags-second-phase-iii-win-for-acromegaly-heads-for-nda-submission-/

    BIOSPACE
    20 Mar 2024
    Share Share
    Crinetics™Endpoints in the Phase 3 PATHFNDR-2 Study in Acromegaly Patients
    Crinetics™Endpoints in the Phase 3 PATHFNDR-2 Study in Acromegaly Patients

    https://www.globenewswire.com/news-release/2024/03/19/2848371/0/en/Crinetics-Once-Daily-Oral-Paltusotine-Achieved-the-Primary-and-All-Secondary-Endpoints-in-the-Phase-3-PATHFNDR-2-Study-in-Acromegaly-Patients.html

    GLOBENEWSWIRE
    19 Mar 2024
    Share Share
    Crinetics growth disorder drug sees ph. 2 carcinoid syndrome win
    Crinetics growth disorder drug sees ph. 2 carcinoid syndrome win

    https://www.fiercebiotech.com/biotech/crinetics-moves-growth-disease-drug-towards-phase-3-carcinoid-syndrome-after-phase-2-win

    James Waldron FIERCE BIOTECH
    13 Mar 2024
    Share Share
    Crinetics Announces Positive Topline Results from Phase 2 Trial of Paltusotine
    Crinetics Announces Positive Topline Results from Phase 2 Trial of Paltusotine

    https://www.globenewswire.com//news-release/2024/03/12/2845006/0/en/Crinetics-Announces-Positive-Topline-Results-from-Phase-2-Trial-of-Paltusotine-for-the-Treatment-of-Carcinoid-Syndrome.html

    GLOBENEWSWIRE
    12 Mar 2024
    Share Share
    Crinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Crinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com//news-release/2024/03/11/2844146/0/en/Crinetics-Pharmaceuticals-Announces-March-2024-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    11 Mar 2024
    Share Share
    Crinetics Reports Fourth Quarter and Full Year 2023 Financial Results
    Crinetics Reports Fourth Quarter and Full Year 2023 Financial Results

    https://www.globenewswire.com//news-release/2024/02/28/2837423/0/en/Crinetics-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    28 Feb 2024
    Share Share
    Crinetics Announces Oversubscribed $350 Million Private Placement
    Crinetics Announces Oversubscribed $350 Million Private Placement

    https://www.globenewswire.com//news-release/2024/02/28/2836890/0/en/Crinetics-Pharmaceuticals-Announces-Oversubscribed-350-Million-Private-Placement.html

    GLOBENEWSWIRE
    28 Feb 2024
    Share Share
    Crinetics to Report Fourth Quarter and Full Year 2023 Financial Results
    Crinetics to Report Fourth Quarter and Full Year 2023 Financial Results

    https://www.globenewswire.com//news-release/2024/02/14/2829439/0/en/Crinetics-Pharmaceuticals-to-Report-Fourth-Quarter-and-Full-Year-2023-Financial-Results-on-February-28-2024.html

    GLOBENEWSWIRE
    14 Feb 2024
    Share Share
    Crinetics Announces 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Crinetics Announces 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com//news-release/2024/02/12/2827855/0/en/Crinetics-Pharmaceuticals-Announces-February-2024-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    12 Feb 2024
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search